Weiss Multi-Strategy Advisers’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,799
Closed -$826K 659
2023
Q2
$826K Buy
+6,799
New +$907K 0.02% 555
2023
Q1
Sell
-1,354
Closed -$243K 698
2022
Q4
$243K Buy
+1,354
New +$221K 0.01% 540
2021
Q3
Sell
-25,972
Closed -$6.1M 752
2021
Q2
$6.1M Buy
+25,972
New +$4.64M 0.13% 227
2019
Q1
Sell
-57,500
Closed -$878K 577
2018
Q4
$878K Buy
+57,500
New +$945K 0.04% 311

Other funds holding MRNA

Weiss Multi-Strategy Advisers's MRNA Position: Q3 2023 in Review

Weiss Multi-Strategy Advisers sold out of Moderna (MRNA) in Q3 2023, closing a stake of 6,799 shares — an estimated $826K sold.

Weiss Multi-Strategy Advisers first reported a position in MRNA in Q4 2018 and held it in 4 quarters. The position peaked at $6.1M in Q2 2021. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Weiss Multi-Strategy Advisers reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 6,799 Moderna shares in Q3 2023, an estimated $826K.
  • Weiss Multi-Strategy Advisers first reported a position in Moderna in Q4 2018 and held it in 4 quarters.
  • Weiss Multi-Strategy Advisers's Moderna position peaked at $6.1M in Q2 2021.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.